Xenon Pharmaceuticals (XENE) Competitors $31.97 +0.67 (+2.14%) As of 01:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XENE vs. BBIO, BPMC, VRNA, ROIV, ELAN, RVMD, LEGN, GRFS, TGTX, and NUVLShould you be buying Xenon Pharmaceuticals stock or one of its competitors? The main competitors of Xenon Pharmaceuticals include BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Legend Biotech (LEGN), Grifols (GRFS), TG Therapeutics (TGTX), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. Xenon Pharmaceuticals vs. Its Competitors BridgeBio Pharma Blueprint Medicines Verona Pharma PLC American Depositary Share Roivant Sciences Elanco Animal Health Revolution Medicines Legend Biotech Grifols TG Therapeutics Nuvalent Xenon Pharmaceuticals (NASDAQ:XENE) and BridgeBio Pharma (NASDAQ:BBIO) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability. Does the media favor XENE or BBIO? In the previous week, BridgeBio Pharma had 9 more articles in the media than Xenon Pharmaceuticals. MarketBeat recorded 19 mentions for BridgeBio Pharma and 10 mentions for Xenon Pharmaceuticals. Xenon Pharmaceuticals' average media sentiment score of 0.80 beat BridgeBio Pharma's score of 0.53 indicating that Xenon Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Xenon Pharmaceuticals 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BridgeBio Pharma 7 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is XENE or BBIO more profitable? Xenon Pharmaceuticals has a net margin of 0.00% compared to BridgeBio Pharma's net margin of -524.25%. BridgeBio Pharma's return on equity of 0.00% beat Xenon Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Xenon PharmaceuticalsN/A -32.44% -30.84% BridgeBio Pharma -524.25%N/A -94.43% Which has more volatility and risk, XENE or BBIO? Xenon Pharmaceuticals has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, BridgeBio Pharma has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Do insiders and institutionals have more ownership in XENE or BBIO? 95.5% of Xenon Pharmaceuticals shares are held by institutional investors. Comparatively, 99.9% of BridgeBio Pharma shares are held by institutional investors. 5.5% of Xenon Pharmaceuticals shares are held by company insiders. Comparatively, 18.2% of BridgeBio Pharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, XENE or BBIO? Xenon Pharmaceuticals has higher earnings, but lower revenue than BridgeBio Pharma. BridgeBio Pharma is trading at a lower price-to-earnings ratio than Xenon Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXenon Pharmaceuticals$9.43M260.13-$234.33M-$3.23-9.90BridgeBio Pharma$221.90M36.68-$535.76M-$3.53-12.14 Do analysts rate XENE or BBIO? Xenon Pharmaceuticals presently has a consensus target price of $54.82, suggesting a potential upside of 71.47%. BridgeBio Pharma has a consensus target price of $58.85, suggesting a potential upside of 37.28%. Given Xenon Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts clearly believe Xenon Pharmaceuticals is more favorable than BridgeBio Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Xenon Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 3.00BridgeBio Pharma 0 Sell rating(s) 1 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.93 SummaryXenon Pharmaceuticals beats BridgeBio Pharma on 9 of the 16 factors compared between the two stocks. Get Xenon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XENE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XENE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XENE vs. The Competition Export to ExcelMetricXenon PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.45B$2.88B$5.52B$8.87BDividend YieldN/A2.70%5.36%4.13%P/E Ratio-9.9021.6626.5019.82Price / Sales260.13267.10410.19110.66Price / CashN/A41.2925.8827.49Price / Book3.237.277.945.39Net Income-$234.33M-$55.05M$3.15B$248.34M7 Day Performance-0.62%-0.47%1.08%1.25%1 Month Performance11.32%6.59%5.34%5.41%1 Year Performance-15.18%0.42%32.80%18.07% Xenon Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XENEXenon Pharmaceuticals3.1188 of 5 stars$31.97+2.1%$54.82+71.5%-19.7%$2.45B$9.43M-9.90210BBIOBridgeBio Pharma4.6898 of 5 stars$43.18-3.7%$58.85+36.3%+70.5%$8.52B$221.90M0.00400Analyst ForecastInsider TradeHigh Trading VolumeBPMCBlueprint Medicines1.7456 of 5 stars$128.18+0.1%$128.06-0.1%+18.9%$8.27B$508.82M-51.89640Positive NewsVRNAVerona Pharma PLC American Depositary Share2.5699 of 5 stars$94.58+0.8%$101.10+6.9%+554.1%$7.99B$42.28M0.0030Positive NewsAnalyst ForecastGap UpROIVRoivant Sciences2.0596 of 5 stars$11.27-1.1%$17.50+55.3%+6.6%$7.74B$29.05M0.00860ELANElanco Animal Health2.3362 of 5 stars$14.29flat$15.17+6.1%-1.0%$7.10B$4.44B15.209,000RVMDRevolution Medicines4.4565 of 5 stars$36.79-0.3%$67.58+83.7%-5.2%$6.88B$11.58M0.00250LEGNLegend Biotech2.4079 of 5 stars$35.49+2.5%$76.20+114.7%-19.9%$6.36B$627.24M0.002,609Positive NewsGRFSGrifols4.0604 of 5 stars$9.04+2.0%$10.30+13.9%+43.4%$6.09B$7.81B7.7323,822Analyst DowngradeTGTXTG Therapeutics3.7388 of 5 stars$35.99-2.0%$40.80+13.4%+102.3%$5.83B$329M149.96290NUVLNuvalent2.8483 of 5 stars$76.30-4.2%$119.60+56.7%+0.6%$5.72BN/A0.0040 Related Companies and Tools Related Companies BridgeBio Pharma Alternatives Blueprint Medicines Alternatives Verona Pharma PLC American Depositary Share Alternatives Roivant Sciences Alternatives Elanco Animal Health Alternatives Revolution Medicines Alternatives Legend Biotech Alternatives Grifols Alternatives TG Therapeutics Alternatives Nuvalent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XENE) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XENE Stock Alerts